Clinical Trials Browser

OTHER × Hodgkin Disease × magrolimab × Clear all

NCT04788043 2025-04-02

Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma

Phase 2 Active not recruiting

Hodgkin Disease